Where I see patients (2)
Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.
The British journal of dermatology
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.
Dermatology and therapy
Association Between Atopic Dermatitis and Chronic Obstructive Pulmonary Disease Among US Adults in the 1999-2006 NHANES Survey.
Mean change from baseline in percent of lesional CD4+ T effector cells producing IL-17
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Percentage change from pre-treatment baseline of CD4+ T effector cells expressing IL-4 at weeks 2, 4, 12 in dupilumab-treated patients.